ArticleScandinavian journal of immunology2025

Treat-To-Target: Emergence of Second-Generation CD40L Inhibitors for Treatment of SLE-Identifying Beneficial Patient Candidates for CD40L Inhibitors in a Cross-Sectional SLE Cohort.

Kathrine Pedersen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.